INTEGRATIVE NETWORK MODELLING OF DRUG RESPONSES IN CANCER FOR REVEALING MECHANISM OF ACTION

2021-9-6
Ünsal Beyge, Şeyma
Classification of cancer drugs is crucial for drug repurposing since the cost and innovation deficit make new drug development processes challenging. Heterogeneity of cancer causes drug classification purely based on known mechanism of action (MoA) and the list of target proteins to be insufficient. Multi-omic data integration is necessary for a systems biology perspective to understand molecular mechanisms and interactions between cellular entities underlying the disease. This study integrates drug-target interaction data with transcriptomics and phosphoproteomic data of perturbed cell lines to model drug and cell-specific subnetworks. Total 250 networks are reconstructed, including 70 small molecule drugs on six cell lines. Similarities of reconstructed networks are quantitatively calculated using a topology-based network comparison measure which scores the separation of networks using the shortest paths between network nodes. Different drugs with similar omic outcomes on variable cell lines are revealed with the aid of separation scores. Moreover, the effect of drugs on variable cell lines is discovered together with the impact of target selectivity of drugs within the same MoA group. Functional analysis of reconstructed networks for their enriched cellular pathways further indicated that drugs with different chemical structures and MoA might induce common signaling cascades. As omics data integration coupled network modeling reveals modulated pathways for specific conditions, the methodology of this study is applicable to different drug-disease research areas. Prediction of drug combinations for a given disease and inference of drug similarity based on cell line sensitivity are two applications presented in this study.

Suggestions

Predicting the binding affinities of drug-protein interaction by analyzing the images of binding sites
Erdaş, Özlem; Alpaslan, Ferda Nur; Büyükbingöl, Erdem; Department of Computer Engineering (2013)
Analysis of protein-ligand interactions plays an important role in designing safe and efficient drugs, contributing to drug discovery and development. Recently, machine learning methods have been found useful in drug design, which utilize intelligent techniques to predict unknown protein-ligand interactions by learning from specific properties of known protein-ligand interactions. The aim of this thesis is to propose a novel computational model, Compressed Images for Affinity Prediction (CIFAP), to predict ...
Providing Semantic Interoperability Between Clinical Care and Clinical Research Domains
Laleci, Gokce Banu; Yuksel, Mustafa; Doğaç, Asuman (2013-03-01)
Improving the efficiency with which clinical research studies are conducted can lead to faster medication innovation and decreased time to market for new drugs. To increase this efficiency, the parties involved in a regulated clinical research study, namely, the sponsor, the clinical investigator and the regulatory body, each with their own software applications, need to exchange data seamlessly. However, currently, the clinical research and the clinical care domains are quite disconnected because each use ...
Differential gene expression analysis related to extracellular matrix components in drug-resistant RPMI-8226 cell line
Mutlu, Pelin; Gündüz, Ufuk (Elsevier BV, 2012-4)
Drug resistance remains a major obstacle to the successful use of chemotherapeutic drugs for many types of cancers including multiple myeloma. It is becoming increasingly apparent that tumor microenvironment could provide a shelter to malignant plasma cells that allow their survival after initial drug exposure. This study demonstrates alterations in gene expression levels of several extracellular matrix (ECM) components in prednisone, vincristine and melphalan-resistant RPMI-8226 myeloma cells. Resistant RP...
CpG oligodeoxynucleotide- loaded PAMAM dendrimer-coated magnetic nanoparticles promote apoptosis in breast cancer cells
Pourianazar, Negar Taghavi; Gündüz, Ufuk (2016-03-01)
One major application of nanotechnology in cancer treatment involves designing nanoparticles to deliver drugs, oligonucleotides, and genes to cancer cells. Nanoparticles should be engineered so that they could target and destroy tumor cells with minimal damage to healthy tissues. This research aims to develop an appropriate and efficient nanocarrier, having the ability of interacting with and delivering CpG-oligodeoxynucleotides (CpG-ODNs) to tumor cells. CpG-ODNs activate Toll-like receptor 9 (TLR9), which...
MDeePred: Novel multi-channel protein featurization for deep learning-based binding affinity prediction in drug discovery
Rifaioglu, A.S.; Atalay, R. Cetin; Kahraman, Deniz Cansen; DOĞAN, TUNCA; Martin, M.; Atalay, Mehmet Volkan (2021-03-01)
Motivation: Identification of interactions between bioactive small molecules and target proteins is crucial for novel drug discovery, drug repurposing and uncovering off-target effects. Due to the tremendous size of the chemical space, experimental bioactivity screening efforts require the aid of computational approaches. Although deep learning models have been successful in predicting bioactive compounds, effective and comprehensive featurization of proteins, to be given as input to deep neural networks, r...
Citation Formats
Ş. Ünsal Beyge, “INTEGRATIVE NETWORK MODELLING OF DRUG RESPONSES IN CANCER FOR REVEALING MECHANISM OF ACTION,” Ph.D. - Doctoral Program, Middle East Technical University, 2021.